Mepacrine protects the isolated rat heart during hypoxia and reoxygenation - But not by inhibition of phospholipase A2

Basic Research in Cardiology

Volumn 92, Issue 1, 1997, Pages 17-24

  Bugge, E ^a   Gamst, T M ^a   Hegstad, A C ^a   Andreasen, T ^a   Ytrehus, K ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Hypoxia; Mepacrine; Non esterified fatty acids; Phospholipase A2; Rat heart

Indexed keywords

ANTIMALARIAL AGENT; CREATINE KINASE; FATTY ACID; MEPACRINE; PHOSPHOLIPASE A2; POLYUNSATURATED FATTY ACID;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; HEART INJURY; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; ISOLATED HEART; MALE; NONHUMAN; RAT; REOXYGENATION;

ANIMALS; ANOXIA; ENZYME INHIBITORS; FATTY ACIDS, NONESTERIFIED; HEART; HEMODYNAMIC PROCESSES; MALE; MYOCARDIUM; PERFUSION; PHOSPHOLIPASES A; QUINACRINE; RATS; RATS, WISTAR;

EID: 0031057444     PISSN: 03008428     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003950050013     Document Type: Article

References (32)

1. Armstrong SC, Ganote CE (1991) Effects of the phospholipase inhibitor mepacrine on injury in ischemic and metabolically inhibited adult isolated myocytes. Am J Pathol 138: 545-555
2. Best L, Sener A, Mathias PCF, Malaisse WJ (1984) Inhibition by mepacrine and p-bromophenacylbromide of phosphoinositide hydrolysis, glucose oxidation, calcium uptake and insulin release in rat pancreatic islets. Biochem Pharmacol 33: 2657-2662
3. Bugge E, Ytrehus K (1996) Bradykinin can protect against infarction but does not mediate ischemic preconditioning in the isolated rat heart. J Mol Cell Cardiol, in press
4. Bugge E, Ytrehus K (1995) Inhibition of sodium-hydrogen exchange reduces infarct size in the isolated rat heart - a protective additive to ischaemic preconditioning. Cardiovasc Res 29: 269-274
5. Bugge E, Ytrehus K (1995) Ischaemic preconditioning is protein kinase C dependent but not through stimulation of alpha adrenergic or adenosine receptors in the isolated rat heart. Cardiovasc Res 29: 401-406
6. Chiariello M, Ambrosio G, Cappelli-Bigazzi M, Nevola E, Perrone-Filardi P, Marone G, Condorelli M (1987) Inhibition of ischemia-induced phospholipase activation by quinacrine protects jeopardized myocardium in rats with coronary artery occlusion. J Pharmacol Exp Ther 241: 560-568
7. Chiariello M, Ambrosio G, Cappelli-Bigazzi M, Perrone-Filardi P, Tritto I, Nevola E, Golino P (1990) Reduction of infarct size by the phospholipase inhibitor quinacrine in dogs with coronary artery occlusion. Am Heart J 120: 801-807
8. Das DK, Engelman RM, Rousou JA, Breyer RH, Otani H, Lemeshow S (1986) Role of membrane phospholipids in myocardial injury induced by ischemia and reperfusion. Am J Physiol 251: H71-H79
9. 2+-exchange activity by quinacrine. Am J Physiol 252: C24-C29
10. Kaluzny MA, Duncan LA, Merrit MV, Epps DE (1985) Rapid separation of lipid classes in high yield and purity using bonded phase columns. J Lipids Res 26: 135-140
11. 2 inhibitors, Mepacrine and Chloroquine. Gen Physiol Biophys 8: 113-118
12. Folch J, Lees M, Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipids from animal tissue. J Biol Chem 226: 497-509
13. Freyss-Beguin M, Milllanvoye-van Brussel E, Duval D (1989) Effect of oxygen deprivation on metabolism of arachidonic acid by cultures of rat heart cells. Am J Physiol 257: H444-H451
14. 2 and their membrane substrates. Trends Cardiovasc Med 2: 115-121
15. Grover GJ, Sleph PG (1989) Dissociation of cardiodepression from cardioprotection with calcium antagonists: diltiazem protects ischemic rat myocardium with a lower functional cost as compared with veraparmil or nifedipine. J Cardiovasc Pharmacol 14: 331-340
16. 2 contributes to loss of plasma membrane integrity during chemical hypoxia in rat hepatocytes. Biochem Biophys Res Com 174: 654-659
17. Jones RL, Miller JC, Hagler HK, Chien KR, Willerson JT, Buja M (1989) Association between inhibition of arachidonic acid release and prevention of calcium loading during ATP-depletion in cultured rat cardiac myocytes. Am J Pathol 135: 541-556
18. Karmazyn M, Watson JE, Moffat MP (1990) Mechanisms for cardiac depression induced by phorbol myristate acetate in working rat heart. Br J Pharmacol 100: 826-830
19. Kloner RA, Braunwald E (1987) Effects of calcium antagonists on infarcting myocardium. Am J Cardiol 59: 84B-94B
20. Meng H-P, Maddaford TG, Pierce GN (1993) Effect of amiloride and selected analogues on postischemic recovery of cardiac contractile function. Am J Physiol 264: H1831-H1835
21. Nishida M, Borzak S, Kraemer B, Navas JP, Kelly RA, Smith TW, Marsh JD (1993) Role of cation gradients in hypercontracture of myocytes during simulated ischemia and reperfusion. Am J Physiol 264: H1896-H1906
22. 1 Engelman RM, Rousou JA, Breyer RH, Das DK (1986) Enhanced prostaglandin synthesis due to phospholipid breakdown in ischemic-reperfused myocardium. J Mol Cell Cardiol 18: 953-961
23. Otani H, Prasad R, Jones RM, Das DK (1989) Mechanism of membrane phospholipid degradation in ischemic-reperfused rat hearts. Am J Physiol 257: H252-H258
24. Otani H, Engelman R, Breyer RH, Rousou JA, Lemeshow S, Das DK (1986) Mepacrine, a phospholipase inhibitor. A potential tool for modifying myocardial reperfusion injury. J Thorac Cardiovasc Surg 92: 247-254
25. 2 inhibitors quinacrine and 7,7-dimethyleicosadienoic acid in isolated globally ischemic rat hearts. J Pharmacol Exp Ther 262: 1161-1167
26. + exchange activity in purified canine cardiac sarcolemmal vesicles. J Biol Chem 260: 4869-4876
27. Shen C-Y, Wang D, Chang M-L, Hsu K (1995) Protective effect of mepacrine on hypoxia-reoxygenation-induced acute lung injury. J Appl Physiol 78: 225-231
28. 2-dependent signalling in the heart. Cardiovasc Res 30:518-529
29. van Bilsen M, van der Vusse GJ, Willemsen P, Coumans W, Roemen T, Reneman RS (1990) Effects of nicotinic acid and mepacrine on fatty acid accumulation and myocardial damage during ischemia and reperfusion. J Moll Cell Cardiol 22: 155-163
30. van den Bosch H (1980) Intracellular phospholipases A. Biochimica et Biophysica Acta 604: 191-246
31. van der Vusse GJ, Prinzen FW, van Bilsen M, Engels W, Reneman RS (1987) Accumulation of lipids and lipidintermediates in the heart during ischemia. Basic Res Cardiol 82 (suppl): 157-167
32. 2. Biochem Pharmacol 29: 623-627